03.02.2011 • News • CFO • Dr. Bernhard Düttmann • Lanxess

Dr. Bernhard Düttmann to Become Chief Financial Officer (CFO) of Lanxess

Dr. Bernhard Duettmann, next Lanxess CFO
Dr. Bernhard Duettmann, next Lanxess CFO

The Supervisory Board of Lanxess agreed today to revoke the contract of Matthias Zachert (43), Member of the Board of Management and Chief Financial Officer, as of March 31, 2011. Zachert had requested the Board to do so accordingly. In his current function, he has been a Member of the Board of Management since 2004.

Dr. Bernhard Düttmann (51), previously Member of the Board of Management and Chief Financial Officer of Beiersdorf, Hamburg, has been appointed Member of the Board of Management and Chief Financial Officer of Lanxess as of April 1, 2011.

"The Supervisory Board is pleased to have gained an experienced Chief Financial Officer of a recognized company for the CFO role at Lanxess and would like to wish him success in his new position."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature